This protocol is judged by an institutional evaluation board, an impartial group that assessments any clinical trials involving humans. If a analyze requires a Program I drug, as soon as the board approves the protocol as ethical, the researchers should submit an application for an investigational new drug (IND) amount through the FDA.Together with